Evidence map›Paper›PMID 40182765›Full record

ArticleFrontiers in cellular and infection microbiology2025

The investigation of molecular epidemiological characteristics and resistance mechanism of tigecycline resistant

Yuqiong Li, Shiyu Tang, Qi Han, Peiwen Xia, Tingting Si, Yuanyuan Song, Yun Xia

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Whole-Genome Insights Into Tigecycline-ResistantTransboundary and emerging diseases · 2026
    Article
  2. Acquisition and Transmission ofInfection and drug resistance · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuqiong Li *Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Shiyu Tang *Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Qi HanDepartment of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Peiwen XiaDepartment of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Tingting SiDepartment of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yuanyuan SongDepartment of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yun XiaDepartment of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: We isolated 30 TRKP strains from this hospital between August 2021 and December 2023. By PCR and sequencing, we examined the presence and mutation rates of genes associated with tigecycline resistance, including Results: The mutation rates of Conclusion: The efflux pump

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialKlebsiella InfectionsKlebsiella pneumoniaeTigecyclineBacterial ProteinsChinaDrug Resistance, Multiple, BacterialHospitals, TeachingHumansMembrane Transport ProteinsMicrobial Sensitivity TestsMolecular EpidemiologyMutationAnti-Bacterial AgentsBacterial ProteinsMembrane Transport ProteinsTigecyclineKlebsiella pneumoniaeresistance mechanismRND efflux pumptet(A)tigecycline-resistance

Identifiers

PMID40182765
PMCPMC11965929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.